詳細
 |
Jason Adams VP, Head of Clinical Business Development, Illumina Inc. |
Shaping the Future of Clinical Next Generation Sequencing Testing in Oncology
Highlight Illumina’s vision to build a single Comprehensive Genomic Profiling (CGP) CDx solution for global markets. In the presentation, I will articulate the path to evolve testing infrastructure, gain broad patient access, and how strategic partnerships will help evolve and grow a changing global healthcare landscape in genomic testing. |
Fill Out Form to Access Webinar
ご提供いただいた個人情報は、お客様へのサポート、サービス、および販売活動の目的にのみ使用させていただきます。
- 日時
- 2022/06/30
- Location
- Japan
- Asia
- Presenter
- Jason Adams
VP, Head of Clinical Business Development, Illumina Inc. - Topic
- Cancer research, Cellular & molecular biology, Genetic & rare diseases, Drug discovery & development